Literature DB >> 17219219

Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.

Laurent Naudon1, Maïté Hotte, Thérèse M Jay.   

Abstract

RATIONALE: The cognitive impairments apparent in many depressed patients appear to be alleviated by chronic treatments with antidepressants. However, evaluation of antidepressant treatments in rodents rarely includes investigation of their effects on cognitive performance.
OBJECTIVES: The aim of this study was to investigate in rat the effects of paroxetine, a selective serotonin reuptake inhibitor antidepressant, and imipramine, a tricyclic antidepressant, on learning and memory in spatial and non-spatial tasks.
MATERIALS AND METHODS: Adult male Sprague-Dawley rats weighing 230-250 g were used in two sets of experiments.
RESULTS: Spatial working memory was first tested in a radial-arm maze using the delayed spatial win-shift task. During the course of a 10-day treatment, paroxetine-treated rats (10 mg/kg) did not show any deficit in memory performance. Conversely, imipramine-treated rats (10 mg/kg) made significantly more errors than controls. Secondly, we tested temporal order memory for objects. Rats received one injection or chronic injections (28 days) of imipramine (10 mg/kg), paroxetine (10 mg/kg) or saline. In contrast to controls, on the day after the acute injection, both imipramine- and paroxetine-treated rats were unable to discriminate the old from the recent objects. After chronic treatment, the imipramine-treated rats were unable to differentiate between the two objects, whereas paroxetine-treated rats, as controls, spent more time exploring the old one. When the delay before the test phase was increased to 4 h, controls could not discriminate the objects, whereas rats treated for 28 days with paroxetine were able to distinguish the old from the recent object.
CONCLUSIONS: In contrast to the persistent harmful effects of imipramine, chronic treatment with paroxetine does not alter spatial working memory performance and appears to improve temporal order memory performance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219219     DOI: 10.1007/s00213-006-0660-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on a radial arm maze.

Authors:  S B Floresco; D N Braaksma; A G Phillips
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Working memory for complex scenes: age differences in frontal and hippocampal activations.

Authors:  Denise C Park; Robert C Welsh; Christy Marshuetz; Angela H Gutchess; Joseph Mikels; Thad A Polk; Douglas C Noll; Stephan F Taylor
Journal:  J Cogn Neurosci       Date:  2003-11-15       Impact factor: 3.225

3.  Associative and nonassociative learning after chronic imipramine in rats.

Authors:  Jesper Mogensen; Gitte Svendsen; Klara Tølbøll Lauritsen; Petra Ermens; Andreas Hasman; Soheyla Elvertorp; Per Plenge; Erling Mellerup; Gitta Wörtwein
Journal:  Pharmacol Biochem Behav       Date:  2003-08       Impact factor: 3.533

4.  Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay.

Authors:  S B Floresco; J K Seamans; A G Phillips
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

5.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

6.  Impaired delayed spatial win-shift behaviour on the eight arm radial maze following excitotoxic lesions of the medial prefrontal cortex in the rat.

Authors:  Claire L Taylor; Mary P Latimer; Philip Winn
Journal:  Behav Brain Res       Date:  2003-12-17       Impact factor: 3.332

7.  A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.

Authors:  S L Arminen; U Ikonen; P Pulkkinen; E Leinonen; A Mahlanen; H Koponen; K Kourula; J Ryyppö; V Korpela; M L Lehtonen
Journal:  Acta Psychiatr Scand       Date:  1994-06       Impact factor: 6.392

8.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

9.  Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

Authors:  James M Ferguson; Keith A Wesnes; Gerri E Schwartz
Journal:  Int Clin Psychopharmacol       Date:  2003-01       Impact factor: 1.659

10.  Medial prefrontal cortex is involved in spatial temporal order memory but not spatial recognition memory in tests relying on spontaneous exploration in rats.

Authors:  D K Hannesson; G Vacca; J G Howland; A G Phillips
Journal:  Behav Brain Res       Date:  2004-08-12       Impact factor: 3.332

View more
  16 in total

Review 1.  A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?

Authors:  Paul J Fitzgerald
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

2.  Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice.

Authors:  Suthat Liangpunsakul; Yasmeen Rahmini; Ruth A Ross; Zhenwen Zhao; Yan Xu; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

3.  The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression.

Authors:  Maya First; Irit Gil-Ad; Michal Taler; Igor Tarasenko; Nurit Novak; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2011-04-09       Impact factor: 3.444

4.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

5.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

6.  Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.

Authors:  Brittney R Lins; Stephanie A Ballendine; John G Howland
Journal:  Neurosci Lett       Date:  2013-12-17       Impact factor: 3.046

7.  The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.

Authors:  J Philbert; C Belzung; G Griebel
Journal:  Psychopharmacology (Berl)       Date:  2013-02-14       Impact factor: 4.530

8.  Learning and memory in the forced swimming test: effects of antidepressants having varying degrees of anticholinergic activity.

Authors:  Nurhan Enginar; Pınar Yamantürk-Çelik; Asiye Nurten; Dilvin Berrak Güney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-01       Impact factor: 3.000

9.  Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.

Authors:  Nataly Ladurelle; Cecilia Gabriel; Adela Viggiano; Elisabeth Mocaër; Etienne E Baulieu; Massimiliano Bianchi
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

10.  Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.

Authors:  David Zilles; Jobst Meyer; Thomas Schneider-Axmann; Savira Ekawardhani; Eva Gruber; Peter Falkai; Oliver Gruber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-28       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.